Find information on thousands of medical conditions and prescription drugs.

Ipratropium bromide

Ipratropium is an anticholinergic drug (trade name: Atrovent®) administered by inhalation for the treatment of obstructive lung diseases. It acts by blocking muscarinic receptors in the lung, inhibiting bronchoconstriction and mucus secretion. more...

Home

IFEX

Imdur

Imitrex

Imodium

Indahexal

Indapamide

Inderal

Indocin

Indometacin

Infliximab

INH

Inosine

Intal

Invanz

Iressa

Isordil

Isosorbide mononitrate

Isotretinoin

Itraconazole

Ivermectin

Clinical uses

Ipratropium has respiratory effects similar to atropine but since it is poorly absorbed into the blood, it has few side effects (such as tachycardia) at therapeutic doses.

It is available under the trade names Alti-Ipratropium (AltiMed), Apo-Ipravent (Apotex), Atrovent Inhalation Aerosol (Boehringer Ingelheim), Atrovent Inhalation Solution (Boehringer Ingelheim), Atrovent Nasal Spray (Boehringer Ingelheim), Gen-Ipratropium (Genpharm), Novo-Ipramide (Novopharm), Nu-Ipratropium (Nu-Pharm), PMS-Ipratropuim (Pharmascience).

Sources

Brenner, G. M. (2000). Pharmacology. Philadelphia, PA: W.B. Saunders Company. ISBN 0-7216-7757-6
Canadian Pharmacists Association (2000). Compendium of Pharmaceuticals and Specialties (25th ed.). Toronto, ON: Webcom. ISBN 0-919115-76-4

Read more at Wikipedia.org

• [List your site here Free!]


	Medicare eyes costs for drugs given in office. (Albuterol Ipratropium Bromide Cited).(Brief Article) : An article from: Family Practice News $5.95	Medicare to cut overpay for drugs given in office. (Albuterol, Ipratropium Bromide Cited).(Brief Article) : An article from: Internal Medicine News $5.95


A comparison of the effects of salbutamol and ipratropium bromide on exercise endurance in patients with COPD - clinical investigations - chronic obstructive Study objective: Inhaled bronchodilators are the first-line pharmacotherapy against COPD. The purpose of the present study was to investigate the effects ... From CHEST, 6/1/03 by Toru Oga

In children hospitalized for asthma exacerbations, does adding ipratropium bromide to albuterol and corticosteroids improve outcome? - Patient-Oriented Goggin N, Macarthur C, Parkin PC. Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized ... From Journal of Family Practice, 3/1/02 by Kelly Hayday

Ipratropium bromide hydrofluoroalkane inhalation aerosol is safe and effective in patients with COPD - chronic obstructive pulmonary disease Study objective: To compare the efficacy and safety of ipratropium bromide reformulated with the chlorofluorocarbon (CFC)-free propellant hydrofluoroalkane ... From CHEST, 10/1/01 by James Taylor

Delivery Of Albuterol/Ipratropium Bromide By Pressurized Metered Dose Inhaler Via Small Volume Holding Chambers : A Comparative Invitro Assessment - VHCS J P Mitchell(*); S-L Bates; K J Wiersema; M W Nagel; R W Morton mid J N Schmidt. Trudell Medical International, London, ON, Canada. PURPOSE: To compare ... From CHEST, 10/1/00 by J P Mitchell

Ipratropium Bromide for Acute Asthma Exacerbations Asthma management includes treatment of airflow obstruction and airway hyperresponsiveness to varied stimuli. Treatment of acute exacerbations involves ... From American Family Physician, 1/15/00 by Richard Sadovsky

Ipratropium Bromide In Acute Asthma Exacerbation Clinical question Does the addition of ipratropium bromide to [Beta]-agonist therapy improve outcomes in adults with acute asthma exacerbations? Background ... From Journal of Family Practice, 10/1/99 by Cheryl A. Flynn

Effect of inhalation of salbutamol, beclomethasone dipropionate & ipratropium bromide on mucociliary clearance in some patients with chronic stable Background & objectives: Asthma is now regarded as an inflammatory disease and bronchial inflammation may disrupt mucociliary function. Inhaled drugs may act by improving mucociliary function. The ai From Indian Journal of Medical Research, 4/1/03 by Guleria, R

Effect of Ipratropium Bromide Treatment on Oxygen Saturation and Sleep Quality in COPD Study objectives: Patients with COPD are at risk of experiencing a deterioration in arterial oxygen saturation (Sa[O.sub.2]) during sleep, which is generally most pronounced during rapid eye moveme From CHEST, 5/1/99 by Richard J. Martin

Home

Contact

Resources

Exchange Links

ebay